MMP9 and acute respiratory distress syndrome: In the present study, integrated network analysis and 1H-NMR metabolomics revealed key targets (Tlr4, Ptgs2, Mmp9, and Caspase3) and related metabolites (choline, xanthine, lactate, and 3HB) regulated by YCSND in ALI treatment.